Vol 29, No 3 (2023)
Research paper
Published online: 2023-09-25
Visinin-like Protein (VLP-1) as a potential marker of brain damage after carotid endarterectomy — preliminary study
1
, 2, 3, 4, 5, 6
, 2, 3, 4, 5, 6
DOI: 10.5603/aa.96853
Acta Angiologica 2023;29(3):85-93.
Abstract
Introduction: Stroke is the second leading cause of disability and death worldwide. Carotid endarterectomy (CEA) reduces the incidence of ischemic stroke or death in patients with sympatomatic carotid artery stenosis more effectively than pharmacological therapy alone. Visinin-like protein 1 (VLP-1) is a potential marker of brain injury. An increased serum level of VLP-1 was observed in neurodegenerative diseases, ischemic stroke, and traumatic brain injury.
Material and methods: The objective of the study was to report the changes in serum level concentrations of VLP-1 in patients undergoing CEA. The study group consisted of 22 patients with severe carotid artery stenosis, qualified to CEA. Serum levels of VLP-1 were measured by an enzyme-linked immunosorbent assay (ELISA) test at 24 h before CEA, 12 and 48 h after the surgery.
Results: Serum VLP-1 levels were significantly reduced 48 h after CEA compared to the levels before and 12 h after surgery.
Conclusions: VLP-1 serum level decreases after an uncomplicated CEA in patients with high-grade carotid artery stenosis. Alterations in this curve may be a marker of neurological events after the procedure. Higher VLP-1 baseline levels before CEA may reflect brain damage caused by chronic ischemia.
Keywords: carotid endarterectomycarotid artery stenosisstrokevisinin-like protein
References
- Saini V, Guada L, Yavagal DR. Global Epidemiology of Stroke and Access to Acute Ischemic Stroke Interventions. Neurology. 2021; 97(20 Suppl 2): S6–SS16.
- Yip HK, Sung PH, Wu CJ, et al. Carotid stenting and endarterectomy. Int J Cardiol. 2016; 214: 166–174.
- Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). The Lancet. 1998; 351(9113): 1379–1387.
- Mayberg MR. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. Veterans Affairs Cooperative Studies Program 309 Trialist Group. JAMA: The Journal of the American Medical Association. 1991; 266(23): 3289–3294.
- Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998; 339(20): 1415–1425.
- Ferguson GG, Eliasziw M, Barr HW, et al. The North American Symptomatic Carotid Endarterectomy Trial : surgical results in 1415 patients. Stroke. 1999; 30(9): 1751–1758.
- Gupta N, Corriere MA, Dodson TF, et al. The incidence of microemboli to the brain is less with endarterectomy than with percutaneous revascularization with distal filters or flow reversal. J Vasc Surg. 2011; 53(2): 316–322.
- Backhaus R, Boy S, Fuchs K, et al. Hyperperfusion syndrome after MCA embolectomy - a rare complication? Am J Case Rep. 2013; 14: 513–517.
- Lieb M, Shah U, Hines GL. Cerebral hyperperfusion syndrome after carotid intervention: a review. Cardiol Rev. 2012; 20(2): 84–89.
- Capoccia L, Sbarigia E, Rizzo AR, et al. Contralateral occlusion increases the risk of neurological complications associated with carotid endarterectomy. Int J Vasc Med. 2015; 2015: 942146.
- Braunewell KH, Klein-Szanto AJ. Visinin-like proteins (VSNLs): interaction partners and emerging functions in signal transduction of a subfamily of neuronal Ca2+ -sensor proteins. Cell Tissue Res. 2009; 335(2): 301–316.
- Zhao C, Braunewell KH. Expression of the neuronal calcium sensor visinin-like protein-1 in the rat hippocampus. Neuroscience. 2008; 153(4): 1202–1212.
- Groblewska M, Muszyński P, Wojtulewska-Supron A, et al. The Role of Visinin-Like Protein-1 in the Pathophysiology of Alzheimer's Disease. J Alzheimers Dis. 2015; 47(1): 17–32.
- Liu D, Dong X, Yang R, et al. Visinin-like protein-1 level is associated with short-term functional outcome of acute ischemic stroke: A prospective cohort study. Medicine (Baltimore). 2020; 99(9): e19252.
- Blandini F, Braunewell KH, Manahan-Vaughan D, et al. Neurodegeneration and energy metabolism: from chemistry to clinics. Cell Death Differ. 2004; 11(4): 479–484.
- Laterza OF, Modur VR, Crimmins DL, et al. Identification of novel brain biomarkers. Clin Chem. 2006; 52(9): 1713–1721.
- Stejskal D, Sporova L, Svestak M, et al. Determination of serum visinin like protein-1 and its potential for the diagnosis of brain injury due to the stroke: a pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011; 155(3): 263–268.
- LI Y, WU XQA. STUDY ON THE CORRELATION OF COGNITIVE DYSFUNCTION AFTER STROKE WITH THE LEVELS OF VILIP-1 AND HS-CRP IN SERUM. Acta Medica Mediterranea. 2018 Oct 17. ; 6: 1895–9.
- Tarawneh R, D'Angelo G, Macy E, et al. Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer disease. Ann Neurol. 2011; 70(2): 274–285.
- Hao Y, Liu Xu, Zhu R. Neurodegeneration and Glial Activation Related CSF Biomarker as the Diagnosis of Alzheimer's Disease: A Systematic Review and an Updated Meta- analysis. Curr Alzheimer Res. 2022; 19(1): 32–46.
- Tan Z, Jiang J, Tian F, et al. Serum Visinin-Like Protein 1 Is a Better Biomarker Than Neuron-Specific Enolase for Seizure-Induced Neuronal Injury: A Prospective and Observational Study. Front Neurol. 2020; 11: 567587.
- Lederer CW, Torrisi A, Pantelidou M, et al. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis. BMC Genomics. 2007; 8: 26.
- Liebl MP, Kaya AM, Tenzer S, et al. Dimerization of visinin-like protein 1 is regulated by oxidative stress and calcium and is a pathological hallmark of amyotrophic lateral sclerosis. Free Radic Biol Med. 2014; 72: 41–54.
- Wu Y, Abner EL, Conley C, et al. Preliminary Evaluation of a Novel Point of Care Diagnostic Device for Sports-Related Concussion. Clin J Sport Med. 2022; 32(6): 623–626.
- Shahim P, Mattsson N, Macy EM, et al. Serum visinin-like protein-1 in concussed professional ice hockey players. Brain Inj. 2015; 29(7-8): 872–876.
- Bradley-Whitman MA, Roberts KN, Abner EL, et al. A novel method for the rapid detection of post-translationally modified visinin-like protein 1 in rat models of brain injury. Brain Inj. 2018; 32(3): 363–380.
- Naylor AR, Ricco JB, de Borst GJ, et al. Editor's Choice - Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018; 55(1): 3–81.
- Park SY, Kim J, Kim OJ, et al. Predictive value of circulating interleukin-6 and heart-type fatty acid binding protein for three months clinical outcome in acute cerebral infarction: multiple blood markers profiling study. Crit Care. 2013; 17(2): R45.
- Connolly ES, Winfree CJ, Rampersad A, et al. Serum S100B protein levels are correlated with subclinical neurocognitive declines after carotid endarterectomy. Neurosurgery. 2001; 49(5): 1076–82; discussion 1082.
- Rasmussen LS, Christiansen M, Johnsen J, et al. Subtle brain damage cannot be detected by measuring neuron-specific enolase and S-100beta protein after carotid endarterectomy. J Cardiothorac Vasc Anesth. 2000; 14(2): 166–170.
- Brightwell RE, Sherwood RA, Athanasiou T, et al. The neurological morbidity of carotid revascularisation: using markers of cellular brain injury to compare CEA and CAS. Eur J Vasc Endovasc Surg. 2007; 34(5): 552–560.
- Mussack T, Hauser C, Klauss V, et al. Serum S-100B protein levels during and after successful carotid artery stenting or carotid endarterectomy. J Endovasc Ther. 2006; 13(1): 39–46.
- Terlecki P, Pawlik P, Iwaniuk A, et al. Carotid surgery affects plasma kynurenic acid concentration: a pilot study. Med Sci Monit. 2014; 20: 303–310.
- Ilzecki M, Ilzecka J, Przywara S, et al. Serum Carnosine Dipeptidase 1 and Ubiquitin C - Terminal Hydrolase L1 as Markers of Brain Damage in Patients After Carotid Endarterectomy. Ulutas Med J. 2016; 2(3): 132.
- Ilzecki M, Przywara S, Ilzecka J, et al. Serum microtubule associated protein tau and myelin basic protein as the potential markers of brain ischaemia-reperfusion injury in patients undergoing carotid endarterectomy. Acta Angiologica. 2016; 22(2): 37–43.
- Iłżecki M, Iłżecka J, Przywara S, et al. Effect of carotid endarterectomy on brain damage markers. Acta Neurol Scand. 2017; 135(3): 352–359.
- Ilzecki M, Przywara S, Ilzecka J, et al. Serum glial fibrillary acidic protein as a marker of brain damage in patients after carotid endarterectomy. Acta Angiologica. 2016; 22(1): 1–4.
- Iłżecki M, Iłżecka J, Przywara S, et al. Serum Neuron-Specific Enolase as a Marker of Brain Ischemia-Reperfusion Injury in Patients Undergoing Carotid Endarterectomy. Acta Clin Croat. 2016; 55(4): 579–584.
- Rajeev V, Fann DY, Dinh QN, et al. Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment. Theranostics. 2022; 12(4): 1639–1658.
- Buttgereit J, Qadri F, Monti J, et al. Visinin-like protein 1 regulates natriuretic peptide receptor B in the heart. Regul Pept. 2010; 161(1-3): 51–57.
- Dai FF, Zhang Yi, Kang Y, et al. The neuronal Ca2+ sensor protein visinin-like protein-1 is expressed in pancreatic islets and regulates insulin secretion. J Biol Chem. 2006; 281(31): 21942–21953.
- Gonzalez Guerrico AM, Jaffer ZM, Page RE, et al. Visinin-like protein-1 is a potent inhibitor of cell adhesion and migration in squamous carcinoma cells. Oncogene. 2005; 24(14): 2307–2316.
- Akagi T, Hijiya N, Inomata M, et al. Visinin-like protein-1 overexpression is an indicator of lymph node metastasis and poor prognosis in colorectal cancer patients. Int J Cancer. 2012; 131(6): 1307–1317.